Results 61 to 70 of about 28,978 (256)
Systemic Lupus Erythematosus Presented with Bilateral Orbital Edema and Negative Serology
Case Reports in Rheumatology, 2019 Isolated bilateral periorbital edema with negative serology is an extremely rare presentation of cutaneous lupus erythematosus that may lead to eyelid scarring, infection, or even corneal involvement.
Manal Al-Khaldi, Manal Alsabbagh
doaj +1 more source
Autologous Fat Transfer in a Patient with Lupus Erythematosus Profundus
Case Reports in Dermatology, 2012 Lupus erythematosus profundus, a form of chronic cutaneous lupus erythematosus, is a rare inflammatory disease involving in the lower dermis and subcutaneous tissues. It primarily affects the head, proximal upper arms, trunk, thighs, and presents as firm
Jimi Yoon +5 more
doaj +1 more source
Drugs for discoid lupus erythematosus [PDF]
, 2017 BACKGROUND: Discoid lupus erythematosus (DLE) is a chronic form of cutaneous lupus, which can cause scarring. Many drugs have been used to treat this disease and some (such as thalidomide, cyclophosphamide and azathioprine) are potentially toxic. This is
Grainge, Matthew J. +3 more
core +2 more sources
Scleroderma-Like Lupus Panniculitis: A Case Report and Literature Review
Clinical, Cosmetic and Investigational Dermatology, 2023 Prinpat Pinyowiwat, Suthinee Rutnin, Kumutnart Chanprapaph Division of Dermatology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, ThailandCorrespondence: Kumutnart Chanprapaph, Division of Dermatology ...
Pinyowiwat P, Rutnin S, Chanprapaph K
doaj
Anais Brasileiros de Dermatologia, 2011 Lúpus eritematoso cutâneo crônico é doença autoimune, com apresentações polimorfas que podem, eventualmente, mimetizar outras condições clínicas, causando dificuldade diagnóstica.
Daniela Ferro Farias +4 more
doaj +1 more source
Brief report: Responses to rituximab suggest B cell-independent inflammation in cutaneous systemic lupus erythematosus [PDF]
, 2015 Objective The immunopathogenesis of systemic lupus erythematosus (SLE) is heterogeneous, and responses of skin to rituximab are variable. This study was undertaken to determine the phenotype of rituximab-responsive disease.
Berggren +14 more
core +1 more source
Efficacy and safety of lenalidomide for refractory cutaneous lupus erythematosus [PDF]
, 2012 Introduction: Cutaneous lupus erythematosus (CLE) is a chronic disease characterized by disfigurement and a relapsing course. Thalidomide has proven its efficacy in refractory cutaneous lupus disease, although it is not exempt from significant side ...
Cortés Hernández, Josefina +3 more
core +3 more sources
The Immune Microenvironment: New Therapeutic Implications in Organ Fibrosis
Advanced Science, EarlyView.This review summarizes recent advances in understanding the immune microenvironment's role in fibrosis, focusing on phenotypic/functional alterations of immune cells and their dynamic interactions with other cellular constituents within tissues. The authors further explore therapeutic opportunities and challenges in targeting immune microenvironment ...
Xiangqi Chen +6 more
wiley +1 more source
Current Concepts on Pathogenic Mechanisms and Histopathology in Cutaneous Lupus Erythematosus
Frontiers in Medicine, 2022 Cutaneous lupus erythematosus (CLE) is an interferon (IFN)-driven autoimmune disease that may be limited to the skin or can be associated with systemic lupus erythematosus (SLE).
Tanja Fetter +3 more
doaj +1 more source
Systemic 5-fluorouracil induced lupus erythematosus: a review of the literature [PDF]
, 2019 Drug-induced subacute cutaneous lupus erythematosus (SCLE) is the most common subtype of drug-induced systemic lupus erythematosus and has been associated with more than 100 drugs.
Marsch, Amanda F, Shakhbazova, Anastasia
core